NCT03949374View on ClinicalTrials.gov

Clinical Trial to Evaluate Efficacy and Safety of ROVASRO 10mg Versus CRESTOR 10mg in Hypercholesterolemic Patients

PHASE4CompletedINTERVENTIONAL

Enrollment

126

Participants

Timeline

Start Date

October 23, 2015

Primary Completion Date

April 16, 2018

Study Completion Date

June 1, 2018

Conditions

HypercholesterolemiaDyslipidemias

Interventions

DRUG

CRESTOR, reference formulation of rosuvastatin

Use of ROVASRO for hypercholesterolemia

DRUG

ROVASRO, generic formulation of rosuvastatin

Use of CRESTOR for hypercholesterolemia

Trial Locations (1)

Unknown

Division of Cardiology, Cardiovascular Center, Severance Hospital, Yonsei University College of Medicine, Seoul

All Listed Sponsors

lead

Yonsei University

OTHER

NCT03949374 - Clinical Trial to Evaluate Efficacy and Safety of ROVASRO 10mg Versus CRESTOR 10mg in Hypercholesterolemic Patients | Biotech Hunter | Biotech Hunter